ERBB2 and cancer: The innovative ELISA was utilized for determination of HER2 level in the human cancer cells and the culture medium of lines with a confirmed increased expression of HER2 (SK-OV-3 and SK-BR-3) and MDA-MB-231 cells with low HER2 expression rather than completely lacking the receptor4.